September 2023 – Our New Study: The Burden of Patent Thickets
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
The Next Pandemic with Priti Krishtel and Tahir Amin
Big Pharma fights patent disclosure demand from investors
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Patent reform and lower drug prices should be bipartisan priorities
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
How AbbVie denied Americans access to fair competition for Humira
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
Report pulls no punches in critique of drug patent abuse